Sucheta More

644 total citations
24 papers, 141 citations indexed

About

Sucheta More is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Sucheta More has authored 24 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 3 papers in Surgery. Recurrent topics in Sucheta More's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Lung Cancer Research Studies (6 papers). Sucheta More is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Lung Cancer Research Studies (6 papers). Sucheta More collaborates with scholars based in India, United States and Australia. Sucheta More's co-authors include Kumar Prabhash, Supriya Goud, Vanita Noronha, Vijay Patil, Amit Janu, Rajiv Kumar, Abhishek Mahajan, Alok Goel, Anant Ramaswamy and Chandramani B. More and has published in prestigious journals such as Journal of Clinical Oncology, Oncotarget and Journal of Thoracic Oncology.

In The Last Decade

Sucheta More

19 papers receiving 135 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sucheta More India	6	99	69	34	17	14	24	141
Kathia Cristina Abdalla Brazil	6	40 0.4×	50 0.7×	15 0.4×	35 2.1×	11 0.8×	13	147
A.V. Guizard France	6	61 0.6×	128 1.9×	14 0.4×	5 0.3×	10 0.7×	11	188
Tatiana Hadjieva Bulgaria	5	61 0.6×	47 0.7×	18 0.5×	19 1.1×	5 0.4×	7	154
Miguel Pastor Borgoñón Spain	8	30 0.3×	57 0.8×	21 0.6×	48 2.8×	10 0.7×	13	144
Kato Kambartel Germany	4	150 1.5×	104 1.5×	41 1.2×	59 3.5×		6	184
Yuya Hirasawa Japan	8	71 0.7×	115 1.7×	17 0.5×	21 1.2×		18	172
Céline Mahier - Aït Oukhatar France	8	74 0.7×	70 1.0×	16 0.5×	34 2.0×		17	136
Supriya Goud India	5	88 0.9×	68 1.0×	26 0.8×	14 0.8×		23	116
L. Belmont France	7	73 0.7×	77 1.1×	24 0.7×	37 2.2×		19	154
Sara Manglaviti Italy	7	59 0.6×	72 1.0×	28 0.8×	28 1.6×		23	136

Countries citing papers authored by Sucheta More

Since Specialization

Citations

This map shows the geographic impact of Sucheta More's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sucheta More with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sucheta More more than expected).

Fields of papers citing papers by Sucheta More

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sucheta More. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sucheta More. The network helps show where Sucheta More may publish in the future.

Co-authorship network of co-authors of Sucheta More

This figure shows the co-authorship network connecting the top 25 collaborators of Sucheta More. A scholar is included among the top collaborators of Sucheta More based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sucheta More. Sucheta More is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Menon, Nandini, et al.. (2025). Nutritional status and impact on outcomes of patients with locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: a pre-planned secondary analysis of a phase 3 randomized controlled trial. Journal of the Egyptian National Cancer Institute. 37(1). 48–48.

Ostwal, Vikas, Prabhat Bhargava, S. Srinivas, et al.. (2025). Carica papaya leaf extract (CPLE) versus placebo to improve chemotherapy induced thrombocytopenia (CIT): Results of a phase III triple blinded, randomized placebo controlled trial (PACT study).. Journal of Clinical Oncology. 43(16_suppl). 12008–12008.

Noronha, Vanita, Nandini Menon, Vijay Patil, et al.. (2025). An open label randomized non-inferiority trial comparing adjuvant platinum plus paclitaxel to platinum plus 5-FU after curative resection in high-risk penile carcinoma.. Journal of Clinical Oncology. 43(17_suppl).

Noronha, Vanita, Supriya Goud, Sucheta More, et al.. (2023). A randomized trial of patient navigation with symptom-monitoring in advanced lung cancer.. Journal of Clinical Oncology. 41(17_suppl). LBA1545–LBA1545.

Patil, Vijay, Kavita Nawale, Vanita Noronha, et al.. (2022). Audit of screen failure in 15 randomised studies from a low and middle-income country. ecancermedicalscience. 16. 2 indexed citations

Rao, Abhijith Rajaram, Anant Ramaswamy, Sharath Kumar, et al.. (2022). Prevalence and outcomes of frailty in older patients with cancer: A prospective study from geriatric oncology clinic.. Journal of Clinical Oncology. 40(16_suppl). e24011–e24011. 2 indexed citations

Behel, Vichitra, Vanita Noronha, Vijay Patil, et al.. (2022). Clinical Utility of Liquid Biopsy (Cell-free DNA) Based EGFR Mutation Detection Post treatment Initiation as a Disease Monitoring Tool in Patients With Advanced EGFR-mutant NSCLC. Clinical Lung Cancer. 23(5). 410–418. 11 indexed citations

Noronha, Vanita, Vijay Patil, Nandini Menon, et al.. (2022). Phase III randomized controlled trial comparing chemotherapy to best supportive care in advanced esophageal and gastroesophageal junction cancer.. Journal of Clinical Oncology. 40(16_suppl). 4065–4065. 1 indexed citations

Kapoor, Akhil, Vanita Noronha, Amit Joshi, et al.. (2021). An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settings. ecancermedicalscience. 15. 1274–1274. 2 indexed citations

10.

Mathrudev, Vijayalakshmi, et al.. (2020). Impact of COVID-19 on oncology clinical trials: A “novel“ challenge. Cancer Research Statistics and Treatment. 3(5). 133–133. 4 indexed citations

11.

More, Chandramani B., Naman R. Rao, Sucheta More, & Newell W. Johnson. (2020). Reasons for Initiation of Areca Nut and Related Products in Patients with Oral Submucous Fibrosis within an Endemic Area in Gujarat, India. Substance Use & Misuse. 55(9). 1413–1421. 16 indexed citations

12.

Noronha, Vanita, Amit Joshi, Vijay Patil, et al.. (2019). Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C).. Journal of Clinical Oncology. 37(15_suppl). 9001–9001. 20 indexed citations

13.

Patil, Vijay, Amit Joshi, Vanita Noronha, et al.. (2019). Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer. Oncotarget. 10(59). 6297–6307. 1 indexed citations

14.

Joshi, Amit, Vanita Noronha, Vijay Patil, et al.. (2018). Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational study. ecancermedicalscience. 12. 876–876. 8 indexed citations

15.

Patil, Vijay, Vanita Noronha, Amit Joshi, et al.. (2017). Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma. ESMO Open. 2(1). e000168–e000168. 56 indexed citations

16.

Prabhash, Kumar, Vijay Patil, Anuradha Chougule, et al.. (2017). Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?. Lung India. 35(1). 27–27. 2 indexed citations

17.

Patil, Vijay, Amit Joshi, Abhishek Mahajan, et al.. (2017). P3.02b-094 Rebiopsy Post Progression in EGFR Mutated Lung Cancer. Journal of Thoracic Oncology. 12(1). S1248–S1249. 3 indexed citations

18.

Talreja, Vikas, Vanita Noronha, Vijay Patil, et al.. (2017). P3.02b-055 Impact of Pemetrexed Chemotherapy in Exon 19 or Exon 21 Mutated NSCLC. Journal of Thoracic Oncology. 12(1). S1223–S1223. 1 indexed citations

19.

Noronha, Vanita, Vijay Patil, Amit Joshi, et al.. (2017). Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy. ecancermedicalscience. 11. 776–776. 2 indexed citations

20.

Joshi, Amit, Vanita Noronha, Vijay Patil, et al.. (2017). Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?. PubMed. 2017. 1–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact